2022
DOI: 10.3390/jof8070757
|View full text |Cite
|
Sign up to set email alerts
|

Trichophyton indotineae—An Emerging Pathogen Causing Recalcitrant Dermatophytoses in India and Worldwide—A Multidimensional Perspective

Abstract: Trichophyton (T.) indotineae is a newly identified dermatophyte species that has been found in a near-epidemic form on the Indian subcontinent. There is evidence of its spread from the Indian subcontinent to a number of countries worldwide. The fungus is identical to genotype VIII within the T. mentagrophytes/T. interdigitale species complex, which was described in 2019 by sequencing the Internal Transcribed Spacer (ITS) region of ribosomal DNA of the dermatophyte. More than 10 ITS genotypes of T. interdigital… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
99
0
5

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 92 publications
(140 citation statements)
references
References 63 publications
4
99
0
5
Order By: Relevance
“…In particular, NDM onychomycoses are recalcitrant to terbinafine and azoles, and treatment by topical amphotericin B should be considered as first-line therapy [ 13 , 14 , 15 ]. Drug resistance is also an increasingly recognized concern with some dermatophytes, especially Trichophyton rubrum and Trichophyton mentagrophytes [ 16 , 17 , 18 , 19 , 20 ].…”
Section: Introductionmentioning
confidence: 99%
“…In particular, NDM onychomycoses are recalcitrant to terbinafine and azoles, and treatment by topical amphotericin B should be considered as first-line therapy [ 13 , 14 , 15 ]. Drug resistance is also an increasingly recognized concern with some dermatophytes, especially Trichophyton rubrum and Trichophyton mentagrophytes [ 16 , 17 , 18 , 19 , 20 ].…”
Section: Introductionmentioning
confidence: 99%
“…16,18 A species shift to Trichophyton indotineae is another likely cause of the observed recalcitrance. 19 Taking in consideration the significant number of recalcitrant cases, one of us (DGS) decided to conduct a trial of daily dose fluconazole for patients with dermatophytosis.…”
Section: Discussionmentioning
confidence: 99%
“…The prevalence of superficial mycotic infections is on the rise in the recent time has risen to such a level in the last decades that skin mycoses now affect more than 20-25% of the world's population, making them one of the most frequent forms of infections 13 . The distribution of the dermatomycoses, their causative agents and the prevailing infection patterns vary with geographical location and are also affected by a wide range of environmental and cultural factors [14][15] . In addition, the frequency of dermatomycoses is fostered by low socioeconomic status: crowded living conditions which provide multiple opportunities for skin-to-skin contact.…”
Section: Cjstmentioning
confidence: 99%